ESMO Immuno Oncology Congress Geneva – December 7-10

[vc_row][vc_column width=”1/1″][vc_column_text]

OncoArendi will present a poster on Friday 8th at 12:30 titled: Novel Dual Arginase 1/2 Inhibitor OATD-02 Improves Efficacy of Immune Checkpoint Inhibitors (ESMO Immuno Oncology 2017).

 

 

[/vc_column_text][/vc_column][/vc_row]